1. Home
  2. ENVA vs NAMS Comparison

ENVA vs NAMS Comparison

Compare ENVA & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$168.41

Market Cap

4.1B

Sector

Finance

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$31.46

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
NAMS
Founded
2011
2019
Country
United States
Netherlands
Employees
N/A
100
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.5B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
ENVA
NAMS
Price
$168.41
$31.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$173.00
$46.75
AVG Volume (30 Days)
168.8K
811.6K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
55.05
N/A
EPS
11.52
N/A
Revenue
$3,151,653,000.00
N/A
Revenue This Year
$149.64
$17.96
Revenue Next Year
$16.42
$540.65
P/E Ratio
$14.59
N/A
Revenue Growth
18.58
N/A
52 Week Low
$89.00
$16.79
52 Week High
$176.68
$42.00

Technical Indicators

Market Signals
Indicator
ENVA
NAMS
Relative Strength Index (RSI) 76.71 44.41
Support Level $153.44 $29.73
Resistance Level $176.68 $31.72
Average True Range (ATR) 4.47 1.68
MACD 2.66 -0.28
Stochastic Oscillator 90.66 4.05

Price Performance

Historical Comparison
ENVA
NAMS

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: